NYXH — Nyxoah SA Share News
0.000.00%
- €82.08m
- €52.26m
- €10.02m
Brief: Nyxoah Q1 Revenue EUR 4.3 Million Vs. IBES Estimate EUR 6.02 Million
Belgium's Nyxoah Q4 net revenue jumps 347% on US launch
Brief: Nyxoah Q4 EPS EUR -0.586
Brief: Nyxoah Invests In Further Expanding Its Belgian Manufacturing Capacity To Support Its Worldwide Growth
Brief: Nyxoah Says Co Invests Expanding Its Belgian Manufacturing Capacity
Belgium's Nyxoah Q4 preliminary net revenue beats estimates
Brief: Nyxoah Announces Preliminary Results For The Fourth Quarter And Full Year 2025 And Provides Revenue Guidance For The First Quarter Of 2026
Brief: Nyxoah Q3 Revenue EUR 1.972 Million Vs. IBES Estimate EUR 1.96 Million
Brief: Nyxoah Provides An Update On Expanded Middle East Presence
Brief: Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, INC
Brief: Nyxoah Q2 Gross Profit EUR 850 Thousand
Brief: Nyxoah Says Co Receives Approval From FDA For Genio® System For Treatment Of Obstructive Sleep Apnea
Brief: Nyxoah Provides Update On FDA Approvable Letter For Genio System
Belgium's Nyxoah falls on delayed launch of sleep apnea device
Brief: FDA Issues Approvable Letter For Nyxoah's Genio® System
Brief: Nyxoah SA Files For Mixed Shelf Offering Of Up To $200 Million
Nyxoah SA reports results for the quarter ended December 31 - Earnings Summary
Nyxoah SA expected to post a loss of 46 cents a share - Earnings Preview
Inspire Medical rises after BofA upgrades to 'buy' from 'neutral'